On April 4, 2022, the NIH launched the four-year RECOVER initiative to understand a condition called long COVID and other post-SARS-CoV-2 infection conditions, which the NIH received $1.15 billion from Congress a year prior. [1]
“The condition known as long covid continues to frustrate its sufferers, baffle scientists and alarm people who are concerned about being infected by the coronavirus…. a catchall phrase for persistent symptoms that can range from mild to debilitating and last for weeks, months or longer, is technically known as Post-Acute Sequelae of SARS-CoV-2 [COVID-19] infection, or PASC.”
What would be interesting to understand is how many of the people who were treated early are suffering from “long COVID”? Is Long-COVID associated with the cytotoxicity of the spike protein, and is it “dose” dependent and/or time exposed to spike?